Apixaban
Who holds supplier records for Apixaban? 53 organisations hold a current record for Apixaban: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (36), China (8), Canada (1), Malta (1) and 4 other countries (4); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Apixaban: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/apixaban
Reading the evidence
- 53 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
36 of the 50 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 27 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Apixaban expires 22 May 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (53)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Apixaban. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MOREPEN LABORATORIES LTDIndia Company GMP cert on recordActive DMF 35799, 36641 · latest filing Dec 2021
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 31089, 28009 · latest filing Oct 2016
- Neuland Laboratories LimitedIndiaActive DMF 39444, 32422 · latest filing Jan 2024
- AARTI PHARMALABS LIMITEDIndiaActive DMF 35969 · latest filing Jul 2021
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 29660 · latest filing Sept 2015
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 30060 · latest filing Dec 2015
- ALP PHARM BEIJING CO LTDActive DMF 34954 · latest filing Jun 2020
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 38900 · latest filing Sept 2023
- APISYN HEALTHCARE PRIVATE LIMITEDIndiaActive DMF 42365 · latest filing Aug 2025
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 30704 · latest filing Jul 2016
- Biocon LimitedIndiaActive DMF 35388 · latest filing Dec 2020
- CHANGZHOU PHARMACEUTICAL FACTORYChina Company GMP cert on recordActive DMF 37883 · latest filing Dec 2022
- Cipla LimitedIndia Company GMP cert on recordActive DMF 40964 · latest filing Dec 2024
- COHANCE LIFESCIENCES LTDIndia Company GMP cert on recordActive DMF 34988 · latest filing Jul 2020
- Ctx LifesciencesIndiaActive DMF 40691 · latest filing Oct 2024
- DELMAR CHEMICALS INCCanadaActive DMF 30336 · latest filing Mar 2016
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 29707 · latest filing Sept 2015
- EMNAR PHARMA PRIVATE LTDIndiaActive DMF 41705 · latest filing Apr 2025
- GLOBELA INDUSTRIES PRIVATE LTDActive DMF 44895 · latest filing Sept 2026
- GOLD PHARMA PRIVATE LIMITEDIndiaActive DMF 42920 · latest filing Dec 2025
- HIKAL LTDIndia Company GMP cert on recordActive DMF 32364 · latest filing Dec 2017
- HONOUR LAB LTDIndia Company GMP cert on recordActive DMF 30461 · latest filing May 2016
- INDOCO REMEDIES LTDIndia Company GMP cert on recordActive DMF 30613 · latest filing Jul 2016
- Jiangxi Synergy Pharmaceutical Co., LtdChinaActive DMF 32781 · latest filing Apr 2018
- JUBILANT BIOSYS LTDIndiaActive DMF 32071 · latest filing Nov 2017
- LEE PHARMA LTDIndia Company GMP cert on recordActive DMF 37040 · latest filing Aug 2022
- LINHAI TIANYU PHARMACEUTICAL CO LTDChinaActive DMF 39604 · latest filing Mar 2024
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 38168 · latest filing Apr 2023
- Maithri Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 43954 · latest filing Mar 2026
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 33449 · latest filing Dec 2018
- MEDICHEM MANUFACTURING (MALTA) LTDMalta Company GMP cert on recordActive DMF 30646 · latest filing Jun 2016
- MEGAFINE PHARMA P LTDIndiaActive DMF 40833 · latest filing Jan 2025
- METROCHEM API PRIVATE LTDIndiaActive DMF 35518 · latest filing Dec 2020
- MICRO LABS LTDIndia Company GMP cert on recordActive DMF 30619 · latest filing Aug 2016
- Natco PharmaIndia Company GMP cert on recordActive DMF 30845 · latest filing Sept 2016
- OPTIMUS DRUGS PRIVATE LTDIndiaActive DMF 36651 · latest filing Mar 2022
- RAKSHIT DRUGS PVT LTDIndiaActive DMF 41743 · latest filing May 2025
- RUYUAN HEC PHARM CO LTDActive DMF 30874 · latest filing Aug 2016
- SCINOPHARM TAIWAN LTDTaiwanActive DMF 37669, 30440 · latest filing Dec 2022
- SHAOXING JINGXIN PHARMACEUTICALS CO LTDChinaActive DMF 41163 · latest filing Jan 2025
- SIGMAPHARM LABORATORIES LLCUnited StatesActive DMF 30774 · latest filing Aug 2016
- SMS Pharmaceuticals limitedIndia Company GMP cert on recordActive DMF 33520 · latest filing Jan 2019
- SRINI PHARMACEUTICALS PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 35250 · latest filing Oct 2020
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 30788 · latest filing Sept 2016
- TAPI NL BVNetherlandsActive DMF 30479 · latest filing Jun 2016
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 30929 · latest filing Sept 2016
- Viyash Scientific LtdIndia Company GMP cert on recordActive DMF 39338 · latest filing Apr 2024
- Zakłady Farmaceutyczne Polpharma S.A.Poland Company GMP cert on recordActive DMF 31166 · latest filing Nov 2016
- ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. (No. 36 Kangyang Avenue)ChinaActive DMF 40249 · latest filing Jul 2024
- Zhejiang Huahai Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 29667 · latest filing Sept 2015
- Zhejiang Liaoyuan Pharmaceutical Co., Ltd.ChinaActive DMF 34071 · latest filing Sept 2019
- Zhejiang Supor Pharmaceuticals Co., LtdChina Company GMP cert on recordActive DMF 37770 · latest filing Dec 2022
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 30630 · latest filing Jul 2016
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (4)
Organisations whose Type II DMFs for Apixaban are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- China · Inactive DMF 33298 · filed Oct 2018
- India · Inactive DMF 30635 · filed Jul 2016
- SINTENOVO SA DE CVInactive DMF 30653 · filed Jun 2016
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 30499 · filed Jun 2016
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (8 listed products contain Apixaban). The latest listed patent expires 22 May 2041. The latest listed exclusivity runs to 17 Oct 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Apixaban is an oral anticoagulant medication that works by inhibiting factor Xa, an important component in the blood coagulation pathway. It is commonly used to prevent and treat blood clots and reduce the risk of stroke in patients with atrial fibrillation.
Chemical identity
- IUPAC name
- 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[5,4-c]pyridine-3-carboxamide
- Canonical SMILES
- COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N
- InChIKey
- QNZCBYKSOIHPEH-UHFFFAOYSA-N
- Synonyms
- Apixaban, Eliquis, bms-562247, bms-562247-01
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Factor Xa Inhibitor
- Mechanism of action
- Factor Xa Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Apixaban?
53 organisations hold an active US FDA Type II Drug Master File or a CEP for Apixaban: MOREPEN LABORATORIES LTD (India), MSN Laboratories Private Limited (India), Neuland Laboratories Limited (India), AARTI PHARMALABS LIMITED (India), Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), ALP PHARM BEIJING CO LTD and AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (India), and 45 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Apixaban Drug Master Files are active?
MOREPEN LABORATORIES LTD (DMF 35799, 36641), MSN Laboratories Private Limited (DMF 31089, 28009), Neuland Laboratories Limited (DMF 39444, 32422), AARTI PHARMALABS LIMITED (DMF 35969), Alembic Pharmaceuticals Limited (DMF 29660), ALIVUS LIFE SCIENCES LTD (DMF 30060), ALP PHARM BEIJING CO LTD (DMF 34954) and AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (DMF 38900) and 45 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Apixaban records mean?
4 organisations have only inactive Type II DMFs for Apixaban. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Apixaban?
Yes. The latest patent listed for an approved US product containing Apixaban expires 22 May 2041, across 8 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Apixaban supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Apixaban?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.